Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05607693 | A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects | unknown | Phase 1 | 52 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 15, 2023 | clinicaltrials |
| NCT05856630 | Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg | unknown | Phase 1 | 24 | Luye Pharma Group Ltd.INDUSTRY | 1 | May 12, 2023 | clinicaltrials |
| NCT05854940 | Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate Cancer | unknown | — | 490 | RenJi HospitalOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05354882 | Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology(DEFACTO2) | unknown | N/A | 150 | Université Sorbonne Paris NordOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05823402 | Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)(SPECTacular) | unknown | N/A | 30 | BAMF HealthOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05841992 | Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT04880681 | Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle | unknown | N/A | 60 | Region SkaneOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05246774 | Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer(RABBIO) | unknown | — | 60 | Direction Centrale du Service de Santé des ArméesOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05818631 | Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer | unknown | — | 300 | José Joaquín MiraOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05822726 | The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer | unknown | N/A | 240 | Ruijin HospitalOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT02481648 | Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer(EMMPC) | unknown | N/A | 20 | Vancouver Prostate CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05737004 | Effects of Prostate Cancer on Brain Function | unknown | — | 250 | Shanghai East HospitalOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05815394 | 177Lu-labeled NY108 SPECT Imaging in Patients | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05816668 | Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy(Transamin) | unknown | Phase 3 | 122 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Apr 18, 2023 | clinicaltrials |
| NCT05766163 | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate(COMPAR-P) | unknown | N/A | 150 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05787145 | ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment | unknown | N/A | 300 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04060589 | ReIMAGINE Prostate Cancer Risk | unknown | — | 1,000 | University College, LondonOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05773183 | Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men(MMetdMH) | unknown | — | 60 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT01968538 | Metabolomic Study for Localized Prostate Cancer | unknown | — | 400 | Georgetown UniversityOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT01766492 | Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery(PR-PROS) | unknown | — | 200 | Georgetown UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT01618851 | Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer | unknown | N/A | 70 | Georgetown UniversityOTHER | 0 | Feb 22, 2023 | clinicaltrials |
| NCT05403190 | The Performance of da Vinci SP System on Extraperitoneal Approach Radical Prostatectomy(CGMH-SPEAR-P) | unknown | N/A | 30 | Chang Gung Memorial HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03756077 | A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT01972867 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | unknown | N/A | 6 | Angiodynamics, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05702619 | Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)(HYPROGEN) | unknown | — | 60 | The Christie NHS Foundation TrustOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT05460312 | Protein Kinase A in Prostate Cancer Tissue. | unknown | — | 100 | Ziv HospitalOTHER_GOV | 0 | Jan 26, 2023 | clinicaltrials |
| NCT05700370 | MyProstateScore Equivalency With and Without DRE | unknown | N/A | 800 | LynxDxINDUSTRY | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05533203 | Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) | unknown | Phase 1 | 24 | Shanghai Humantech Biotechnology Co. LtdINDUSTRY | 1 | Jan 23, 2023 | clinicaltrials |
| NCT02759380 | Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?(PRODICA) | unknown | N/A | 240 | Sahlgrenska University HospitalOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05690399 | Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer | unknown | — | 100 | Assiut UniversityOTHER | 0 | Jan 19, 2023 | clinicaltrials |
| NCT03845751 | EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.(ENHANCE) | unknown | Phase 2 | 20 | Institut Mutualiste MontsourisOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05670691 | a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy | unknown | — | 71 | Fudan UniversityOTHER | 0 | Jan 11, 2023 | clinicaltrials |
| NCT05249712 | Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer | unknown | Phase 2 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 3, 2023 | clinicaltrials |
| NCT05667636 | Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP(esSBRT) | unknown | Phase 2 | 103 | Regina Elena Cancer InstituteOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT04356430 | Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer | unknown | Phase 2 | 75 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT02446366 | Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery | unknown | N/A | 24 | University of Southern CaliforniaOTHER | 1 | Dec 12, 2022 | clinicaltrials |
| NCT05644197 | Multidisciplinary Care After Prostatectomy(MCAP) | unknown | N/A | 100 | Provence Private hospitalOTHER | 0 | Dec 9, 2022 | clinicaltrials |
| NCT04833517 | Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | unknown | — | 500 | Universität des SaarlandesOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05631080 | Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer | unknown | Phase 4 | 50 | Mansoura UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05612841 | A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting(IN-PROVE) | unknown | — | 264 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05603351 | Prostate Cancer Screening With Abbreviated MRI Protocol(ProstaPilot) | unknown | N/A | 300 | Masaryk Memorial Cancer InstituteOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04457882 | Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube | unknown | N/A | 112 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05025527 | Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | unknown | N/A | 500 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05596851 | Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. | unknown | — | 15 | European Institute of OncologyOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT03936127 | Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy | unknown | N/A | 360 | Dr. Nicola SchiedaOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05167175 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | unknown | Phase 2 | 30 | Hongqian GuoOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion(CRADT) | unknown | N/A | 70 | Tongji HospitalOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT04026230 | Impact of Atorvastatin on Prostate Cancer Progression During ADT(ESTO2) | unknown | Phase 3 | 400 | Tampere University HospitalOTHER | 4 | Oct 21, 2022 | clinicaltrials |
Data updated 22 days agoSource updated May 15, 2023source: clinicaltrials